PCP
KYMR icon

Proficio Capital Partners’s Kymera Therapeutics KYMR Stock Holding History

Proficio Capital Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
11,045
+200
+2% +$17.2K 0.05% 177
2026
Q1 		$903K Hold
10,845
– – 0.05% 139
2025
Q4 		$844K Buy
10,845
+3,845
+55% +$260K 0.06% 135
2025
Q3 		$396K Hold
7,000
– – 0.03% 144
2025
Q2 		$305K Buy
+7,000
New +$241K 0.02% 320

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Proficio Capital Partners's KYMR Position: Q2 2026 in Review

Proficio Capital Partners increased its Kymera Therapeutics (KYMR) stake by 1.8% in Q2 2026, buying an estimated $17.2K and bringing the position to 11,045 shares worth $1.27M. The position accounts for 0.05% of the portfolio, ranked #177.

Proficio Capital Partners first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Proficio Capital Partners held 11,045 shares of Kymera Therapeutics worth $1.27M as of Q2 2026.
  • Proficio Capital Partners bought 200 Kymera Therapeutics shares in Q2 2026, an estimated $17.2K.
  • Kymera Therapeutics made up 0.05% of Proficio Capital Partners's portfolio in Q2 2026, its #177 holding.
  • Proficio Capital Partners first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.